Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.

Hovorka R, Nodale M, Haidar A, Wilinska ME.

Diabetes Technol Ther. 2013 Jan;15(1):4-12. doi: 10.1089/dia.2012.0185. Epub 2012 Oct 9.

2.

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.

Thabit H, Leelarathna L, Wilinska ME, Elleri D, Allen JM, Lubina-Solomon A, Walkinshaw E, Stadler M, Choudhary P, Mader JK, Dellweg S, Benesch C, Pieber TR, Arnolds S, Heller SR, Amiel SA, Dunger D, Evans ML, Hovorka R.

Diabetes Technol Ther. 2015 Nov;17(11):801-7. doi: 10.1089/dia.2015.0062. Epub 2015 Aug 4.

3.

Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy.

Kumareswaran K, Elleri D, Allen JM, Caldwell K, Nodale M, Wilinska ME, Amiel SA, Hovorka R, Murphy HR.

Diabetes Technol Ther. 2013 Mar;15(3):223-9. doi: 10.1089/dia.2012.0292. Epub 2013 Feb 27.

4.

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB.

Lancet. 2010 Feb 27;375(9716):743-51. doi: 10.1016/S0140-6736(09)61998-X. Epub 2010 Feb 4.

5.

Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.

Thabit H, Elleri D, Leelarathna L, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Barnard KD, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2015 May;17(5):452-8. doi: 10.1111/dom.12427. Epub 2015 Jan 9.

6.

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M.

Diabetes Care. 2009 Dec;32(12):2245-50. doi: 10.2337/dc09-0750. Epub 2009 Sep 18.

7.

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.

Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML.

BMJ. 2011 Apr 13;342:d1855. doi: 10.1136/bmj.d1855.

8.

Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.

Leelarathna L, Nodale M, Allen JM, Elleri D, Kumareswaran K, Haidar A, Caldwell K, Wilinska ME, Acerini CL, Evans ML, Murphy HR, Dunger DB, Hovorka R.

Diabetes Technol Ther. 2013 Feb;15(2):143-9. doi: 10.1089/dia.2012.0245. Epub 2012 Dec 20.

9.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

10.

Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.

Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple R, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R.

Diabetes Care. 2011 Feb;34(2):406-11. doi: 10.2337/dc10-1796. Epub 2011 Jan 7.

11.

Continuous glucose monitors: current status and future developments.

Lane JE, Shivers JP, Zisser H.

Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):106-11. doi: 10.1097/MED.0b013e32835edb9d. Review.

PMID:
23422244
12.

Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.

Thabit H, Lubina-Solomon A, Stadler M, Leelarathna L, Walkinshaw E, Pernet A, Allen JM, Iqbal A, Choudhary P, Kumareswaran K, Nodale M, Nisbet C, Wilinska ME, Barnard KD, Dunger DB, Heller SR, Amiel SA, Evans ML, Hovorka R.

Lancet Diabetes Endocrinol. 2014 Sep;2(9):701-9. doi: 10.1016/S2213-8587(14)70114-7. Epub 2014 Jun 16.

13.

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.

14.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

15.

Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I.

Diabetes Technol Ther. 2011 Nov;13(11):1109-13. doi: 10.1089/dia.2011.0081. Epub 2011 Jul 13.

PMID:
21751889
16.

Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.

Nimri R, Atlas E, Ajzensztejn M, Miller S, Oron T, Phillip M.

Diabetes Technol Ther. 2012 Aug;14(8):728-35. doi: 10.1089/dia.2012.0004.

PMID:
22853723
17.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
18.

Outpatient assessment of determinants of glucose excursions in adolescents with type 1 diabetes: proof of concept.

Maahs DM, Mayer-Davis E, Bishop FK, Wang L, Mangan M, McMurray RG.

Diabetes Technol Ther. 2012 Aug;14(8):658-64. doi: 10.1089/dia.2012.0053.

19.

Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.

Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R.

Pediatr Diabetes. 2012 Sep;13(6):449-53. doi: 10.1111/j.1399-5448.2012.00903.x. Epub 2012 Jul 23.

PMID:
22817340
20.

Automated overnight closed-loop glucose control in young children with type 1 diabetes.

Elleri D, Allen JM, Nodale M, Wilinska ME, Mangat JS, Larsen AM, Acerini CL, Dunger DB, Hovorka R.

Diabetes Technol Ther. 2011 Apr;13(4):419-24. doi: 10.1089/dia.2010.0176. Epub 2011 Feb 28.

PMID:
21355719

Supplemental Content

Support Center